CClinicalTrials.gg
RecruitingNCT00670735Updated May 14, 2026

HCRN Core Data Project: Characterizing Patient Populations in the Hydrocephalus Clinical Research Network (HCRN)

An observational study in Pediatric Hydrocephalus, sponsored by University of Utah. Recruiting at 14 sites in 2 countries. Open to participants aged Up to 18 Years. Per ClinicalTrials.gov, last updated 2026-05-14.

Sponsored by University of Utah · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,400
Ages
Up to 18 Years
Sex
All
01

Study summary

The Hydrocephalus Clinical Research Network (HCRN) has been established by philanthropic funding to conduct multi-institutional research (clinical trials and observational studies) on pediatric hydrocephalus. In addition to philanthropic funding, the HCRN has also received an NIH NINDS Challenge Grant to support the network infrastructure which allows for the conduct of this and other network studies. The HCRN consists of multiple Clinical Centers and the Data Coordinating Center (DCC). The HCRN Core Data Project will obtain data about all neurosurgical hydrocephalus events from the network Clinical Centers, and create a database to be used by HCRN investigators. The ongoing maintenance of the Core Data Project serves two main purposes: 1) it will help investigators understand the variability, progression, and current treatment practices for hydrocephalus in children, with an ultimate goal of better guiding and assessing therapeutic intervention and providing recommendations on patient care and, 2) it will provide pilot and descriptive data necessary for hypothesis generation and study design (i.e. preliminary power analyses, recruitment projections) for studies under development by the HCRN. This multi-institutional database will be maintained throughout the lifetime of the HCRN, and may be useful for tracking trends in pediatric hydrocephalus over time. The Core Data Project will be an invaluable resource to the HCRN and will help stimulate new research protocols, identify potential need for future expansion of the network to incorporate additional patient populations, and provide a descriptive understanding of children with hydrocephalus cared for within the network.

02

Conditions studied

  • Pediatric Hydrocephalus

Keywords

  • Pediatric Hydrocephalus
03

In context

Lead sponsor

University of Utah is the lead sponsor of 969 studies on the registry; 178 are open to participants now.

Of its 107 completed or terminated interventional studies of FDA-regulated products, 62 (58%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Pediatric Hydrocephalus patients.

Inclusion criteria

Information for all neurosurgical hydrocephalus patient events will be obtained from each HCRN Clinical Center and will be placed continuously into the Core Data Project. The first calendar year will be 2008, and data collection will continue for the duration of the existence of the HCRN. Neurosurgical hydrocephalus patient events include any operation for the treatment of documented hydrocephalus including the following:

  • Ventriculoperitoneal shunt
  • Ventriculoatrial shunt
  • Ventriculopleural shunt
  • Arachnoid cyst shunts
  • Subdural shunts
  • Lumboperitoneal shunts
  • Shunts replaced after treatment of infection
  • Shunts exposed during an operations but not revised
  • Endoscopic third ventriculostomies
  • Ommaya reservoir(s)
  • Ventricular access devices/reservoirs
  • Subgaleal shunts.

Exclusion criteria

Exclusion Criteria:

The following temporary cerebrospinal fluid (CSF) diversion procedures will not be included in the Core Date Project:

  • External ventricular drain(s)
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,400 participants (estimated)
06

What researchers measure

Primary outcomes

  1. To describe the number and characteristics of neurosurgical hydrocephalus patient events to HCRN Clinical Centers such as patient demographics, etiology of hydrocephalus, diagnostic information, as well as surgical and medical management decisions.

    Time frame: 5+ years

Secondary outcomes

  1. To provide this data to HCRN investigators to support hypothesis generation and study design development for clinical trials and observational studies to be carried out by the HCRN.

    Time frame: 5+ years

07

Study locations

13 of 14 sites recruiting
  • Children's Hospital of Alabama, University of Alabama
    Birmingham, Alabama 35233, United States
    • Anastasia Arynchyna, MPH · Contact · arynch@uab.edu · 205-638-5018
    • Curtis J Rozzelle, MD · Principal investigator
    Recruiting
  • Children's Hospital of Los Angeles
    Los Angeles, California 90027, United States
    • Christina Artime, BSN, MSHCM · Contact · cartime@chla.usc.edu · 323-361-7757
    • Mark Krieger, MD · Principal investigator
    Recruiting
  • Children's Hospital Colorado
    Aurora, Colorado 80045, United States
    Recruiting
  • Johns Hopkins Children's Center
    Baltimore, Maryland 21287, United States
    • Adam Loudermilk · Contact · alouder1@jhmi.edu · 410-502-4031
    • Edward Ahn, MD · Principal investigator
    Not yet recruiting
  • St. Louis Children's Hospital
    St Louis, Missouri 63110, United States
    • Mohamed Gabir · Contact · mgabir@wustl.edu · 314-454-5498
    • David Limbrick, MD, PhD · Principal investigator
    Recruiting
  • Nationwide Children's Hospital
    Columbus, Ohio 43205, United States
    Recruiting
  • Children's Hospital of Pittsburgh of UPMC
    Pittsburgh, Pennsylvania 15224, United States
    • Kimberly Diamond, BS, BA · Contact · Kldiamond@pitt.edu · 412-692-9965
    • Mandeep S Tamber, MD, PhD · Principal investigator
    Recruiting
  • Monroe Carell Jr. Children's Hospital at Vanderbilt
    Nashville, Tennessee 37232, United States
    • Deonte Dawson, BS · Contact · deonte.dawson@vanderbilt.edu · 615-343-3251
    • John C Wellons, III, MD, MSPH · Principal investigator
    • Chevis N Shannon, MBA, DrPH · Principal investigator
    • Robert Naftel, MD · Principal investigator
    Recruiting
  • Texas Children's Hospital
    Houston, Texas 77030, United States
    Recruiting
  • Primary Children's Hospital
    Salt Lake City, Utah 84118, United States
    Recruiting
  • Seattle Children's Hospital
    Seattle, Washington 98105, United States
    Recruiting
  • Alberta Children's Hospital
    Calgary, Alberta T3B 6A8, Canada
    • Salim Ahmed, MSc · Contact · salahmed@ucalgary.ca · 403-955-5738
    • Jay Riva-Cambrin, MD · Principal investigator
    Recruiting
  • British Columbia Children's Hospital
    Vancouver, British Columbia V6H 3V4, Canada
    • Alexander Cheong, BSc · Contact · alexander.cheong@cw.bc.ca · 604-875-2345
    • Patrick McDonald, MD · Principal investigator
    • Mandeep S Tamber, MD, PhD · Principal investigator
    Recruiting
  • Sick Children's Hospital
    Toronto, Ontario, Canada
    Recruiting
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00670735
Lead sponsor
University of Utah
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS)
Responsible party
richard holubkov (Ph.D., University of Utah) — Principal investigator
First posted
May 2, 2008
Start date
Apr 2008
Primary completion
Dec 2029 (estimated)
Completion
Dec 2029 (estimated)
Last update
May 14, 2026

Study contacts

Marcie Langley
Contact
marcie.langley@hsc.utah.edu
801-662-5364
Jay Riva-Cambrin, MD
study chair · Alberta Children's Hospital
Abhaya Kulkarni, MD, PhD
principal investigator · Sick Children's Hospital, Toronto, Ontario
Tamara D Simon, MD, MSPH
principal investigator · University of Washington / Seattle Children's Hospital
Richard Holubkov, Ph.D.
principal investigator · University of Utah

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion